// COMPANY
Ajax Therapeutics
SECTOR BIOTECHMENTIONS 2LAST SEEN APRIL 27, 2026
// OVERVIEW
Cancer drug developer backed by Goldman Sachs Asset Management, acquired by Eli Lilly.
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
m_and_a·PitchBook News·APRIL 28, 2026
“Ajax Therapeutics — Cancer drug developer backed by Goldman Sachs Asset Management — Acquired by Eli Lilly for up to $2.3 billion”
02
m_and_a·Axios Pro Rata·APRIL 27, 2026
“Eli Lilly agreed to acquire Ajax Therapeutics for up to $2.3B.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.